MEDIHART
ActiveMEDIHART has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €221k and a net result of €75k. Equity is growing by ~14.9% per year across the filed fiscal years. Its solvency ranks better than 61% of 19908 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
97
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100▲+3
Solvency100▲+15
Growth78=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €21k at 30 days acceptable
Liquidity ample (current ratio 4.12 against 1.85 in 2023; short-term debt: 14.5% and cash: 28.2% of total assets), and 24% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 25-07-2025, 6 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
6 d early
2023
55 d early
2022
31 d late
2021
12 d late
2020
31 d late
2019
70 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€221k▲ 51.5%
2023 · €146k
2018: €92k
2019: €89k
2020: €90k
2021: €111k
2022: €122k
2023: €146k
2018 → 2024
Total assets
€291k▲ 20.5%
2023 · €242k
2018: €268k
2019: €256k
2020: €270k
2021: €285k
2022: €250k
2023: €242k
2018 → 2024
Net result
€75k▲ 40.0%
2023 · €54k
2018: €15k
2019: €17k
2020: €46k
2021: €65k
2022: €37k
2023: €54k
2018 → 2024
Working capital
€132k▲ 168%
2023 · €49k
2018: €6k
2019: €-28k
2020: €-25k
2021: €-3k
2022: €19k
2023: €49k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€90k-€111k▲ 22.5%€122k▲ 10.7%€146k▲ 19.4%€221k▲ 51.5%
Operating result€70k-€91k▲ 30.0%€52k▼ 42.4%€81k▲ 54.1%€115k▲ 42.3%
Net result€46k-€65k▲ 42.3%€37k▼ 43.7%€54k▲ 46.0%€75k▲ 40.0%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 42% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €291k
Fixed assets
€117k▼ 13.3%
Current assets
€175k▲ 62.8%
Equity and liabilities €291k
Equity
€221k▲ 51.5%
Debt
€70k▼ 26.8%
The debt ratio falls from 39.5% to 24.0%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€142k▲
2023 · €110k
Cash flow
€102k▲
2023 · €83k
Solvency
76.0%▲
2023 · 60.5%
Current ratio
4.12▲
2023 · 1.85
Quick ratio
4.12▲
2023 · 1.85
Debt / equity
0.32▼
2023 · 0.65
ROE
34.0%▼
2023 · 36.8%
ROA
25.8%▲
2023 · 22.2%
Interest coverage
46.77▲
2023 · 41.01
Debt
€70k▼
2023 · €96k
Debt ≤ 1 year
€42k▼
2023 · €58k
Debt > 1 year
€28k▼
2023 · €38k
Income taxes
€36k▲
2023 · €24k
Staff costs
€45k▼
2023 · €61k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€242k€291k▲
Fixed assets21/28€134k€117k▼
Tangible fixed assets22/27€134k€117k▼
Land and buildings22€102k€85k▼
Plant, machinery and equipment23€20k€16k▼
Furniture and vehicles24€12k€16k▲
Current assets29/58€107k€175k▲
Amounts receivable within one year40/41€443-
Trade receivables40€443-
Current investments50/53€64k€89k▲
Cash at bank and in hand54/58€38k€82k▲
Deferred charges and accrued income490/1€5k€3k▼
Equity and liabilities
Total equity and liabilities10/49€242k€291k▲
Equity10/15€146k€221k▲
Contributions10/11€2k€2k=
Reserves13€144k€219k▲
Distributable reserves133€144k€219k▲
Amounts payable17/49€96k€70k▼
Amounts payable after more than one year17€38k€28k▼
Financial debts170/4€38k€28k▼
Amounts payable within one year42/48€58k€42k▼
Current portion of amounts payable after more than one year42€10k€10k▲
Trade debts44€58€760▲
Suppliers440/4€58€760▲
Taxes, remuneration and social security45€20k€21k▲
Taxes450/3€9k€15k▲
Remuneration and social security454/9€11k€6k▼
Other amounts payable47/48€28k€10k▼
Income statement
Code20232024
Remuneration, social security and pensions62€61k€45k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€29k€27k▼
Other operating charges640/8€3k€3k▲
Gross operating margin9900€173k€190k▲
Operating profit (loss)9901€81k€115k▲
Financial income75/76B-€6
Recurring financial income75-€6
Financial charges65/66B€3k€3k▲
Recurring financial charges65€3k€3k▲
Profit (loss) for the period before taxes9903€78k€112k▲
Income taxes67/77€24k€36k▲
Profit (loss) for the period9904€54k€75k▲
Profit (loss) for the period to be appropriated9905€54k€75k▲
Appropriation of the result
Profit (loss) to be appropriated9906€54k€75k▲
Transfer to equity691/2€34k€75k▲
To other reserves6921€34k€75k▲
Profit to be distributed694/7€20k-
Return on contributions (dividend)694€20k-
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
25-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2018net €75k ▲40%
Operating result €115k, net result €75k, both a record.
31-12
Financial
Liquidity doublescurrent ratio 4.12
Current ratio from 1.85 to 4.12; short-term debt falls from €58k to €42k.
31-12
Financial
Equity above €200kEq €221k ▲51.5%
7 profitable years in a row build equity to €221k.
06-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
12-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 12 days late
2021
31-12
Financial
Equity above €100kEq €111k ▲22.5%
4 profitable years in a row build equity to €111k.
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
09-10
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 70 days late
2019
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 30 days late
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 30 days late
2017
02-06
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
2016
22-04
NBB filing
Annual accounts filed
fiscal year 2015 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Koekelberg · 2 establishment units since 2011
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Emile Derooverstraat 91081 KoekelbergGround area
1,190 m²
Building footprint
799 m²
Volume, LiDAR
13,417 m³
2 parcels, Brussels · tallest building 28.2 m, ±7 floors. Linked by address, not a title deed.
2 establishment units
MEDIHART
since 20112.197.131.162
MEDIHART
since 20202.308.402.931
2 parcels
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21011A0040/00F013 | Brussels | 985 m² | 1 · 713 m² | 28.2 m · 7 fl. |
| 21011A0040/00S003 | Brussels | 205 m² | 1 · 86 m² | 13.5 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Drs. Vandenecker - Decock
BE 0789.333.639
Maarkedal · Eq €221k
DOKTER ELS JOUCK
BE 0653.961.825
Hasselt · Eq €221k
Dr. Cadron Annelies Huisarts
BE 0725.659.770
Beveren-Kruibeke-Zwijndrecht · Eq €221k
Dokter Lisa Vander Stichele
BE 0798.110.753
Zedelgem · Eq €221k
Dr. Panis Karolien - huisarts
BE 0777.511.220
Lanaken · Eq €221k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,341 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded16-02-2011
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers
Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.